Scale without the premium. Introducing VITARI™ 
Contact Us

      Technology Access Program

      Figure 1. Enzymes built to shorten cycle times also improve base quality, even at 300 bp read ends. Comparing data from human whole-genome libraries demonstrates the ABC accuracy advantage.*
      1200x400-v3-1
      Figure 1. Enzymes built to shorten cycle times also improve base quality, even at 300 bp read ends. Comparing data from human whole-genome libraries demonstrates the ABC accuracy advantage.*

      Get access to groundbreaking technology with your samples and see first-hand how it can transform your research.

      Our TAP program is currently open to submissions for 3’ transcriptome and other pre-commercial applications for Direct In Sample Sequencing (DISS) on AVITI24™.

      AVITI24 Applications

      AVITI24 is the first and only platform to enable in situ multiomics and next generation sequencing.  AVITI24 multiomics simultaneously visualizes RNA, protein, and cell morphology at single-cell, spatial resolution with no library prep.

      This integrated approach is particularly well suited for CRISPR-based functional genomics and drug screening applications, where linking perturbations to multiomic phenotypes at scale is critical. Coming soon on the platform is the capability to screen hundreds of thousands of cells with parallel readouts of cell morphology, 3’ transcriptome, guide RNAs, and protein.

      How it works

      Number-1 Speak to the Element team to discuss your project and assess eligibility.
      Number-2 Send in your samples in the relevant format for our team to run.
      Number-3 Receive your data and review with scientists at Element.

      Space is limited, contact us to get started today:

      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.